Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse

This study investigated the kinetics in HBsAg and the HBsAg loss rate after entecavir or tenofovir disoproxil fumarate (TDF) cessation in patients with chronic hepatitis B (CHB) who achieved virological suppression after virological relapse without clinical relapse. A total 504 HBeAg-negative, non-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Tzu-Ning, Kuo, Yuan-Hung, Hu, Tsung-Hui, Hung, Chao-Hung, Wang, Jing-Houng, Lu, Sheng-Nan, Chen, Chien-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227936/
https://www.ncbi.nlm.nih.gov/pubmed/35746660
http://dx.doi.org/10.3390/v14061189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227936/
https://www.ncbi.nlm.nih.gov/pubmed/35746660
http://dx.doi.org/10.3390/v14061189

Ejemplares similares